Product Information
ATIVAN 2 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $75.9602 per EA under NDC 00187006501. Its NADAC has been published 199 times since Feb 12, 2014.
The High Outlier badge above means this manufacturer's average price in the lorazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Bausch Health US LLCNDC
00187006501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/1/2025
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA017794On Market Since
5/1/2013
Pharmacological Classes
Price Statistics
The NADAC for ATIVAN 2 MG TABLET has been published 199 times since Feb 12, 2014, and over the history we have for it it has risen 605.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $75.9602 per EA |
|---|---|
| All-time high | $75.9602 (Oct 1, 2025) |
| All-time low | $10.7734 (Feb 12, 2014) |
| 52-week high | $75.9602 |
| 52-week low | $75.9602 |
| Median price | $40.3975 |
| Average price | $44.2747 |
| Largest weekly change | +73.9% (Jun 19, 2024) |
| Weeks tracked | 199 |
| Tracking since | Feb 12, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATIVAN 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATIVAN 2 MG TABLET, manufactured by Bausch Health US LLC, is $75.9602 per EA (NDC 00187006501), effective Oct 1, 2025.
How has the price of ATIVAN 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATIVAN 2 MG TABLET has risen 605.1%. It has been tracked across 199 weekly CMS publications since Feb 12, 2014.
What are the highest and lowest recorded NADAC prices for ATIVAN 2 MG TABLET?
Since Feb 12, 2014, the NADAC for ATIVAN 2 MG TABLET has ranged from a low of $10.7734 (Feb 12, 2014) to a high of $75.9602 (Oct 1, 2025), with a median of $40.3975 per EA.
Are there cheaper alternatives to ATIVAN 2 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LOREEV XR 2 MG CAPSULE, is $14.2258 per EA — about 81% below ATIVAN 2 MG TABLET.
Who manufactures ATIVAN 2 MG TABLET?
ATIVAN 2 MG TABLET (NDC 00187006501) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification